BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 35957826)

  • 21. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preanalytical validation and reference values for a mass spectrometric assay of serum vanillylmandelic acid for screening of catecholamine secreting neuroendocrine tumors.
    Tohmola N; Itkonen O; Turpeinen U; Joenväärä S; Renkonen R; Hämäläinen E
    Clin Chim Acta; 2015 Jun; 446():206-12. PubMed ID: 25896957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
    van Berkel A; Lenders JW; Timmers HJ
    Eur J Endocrinol; 2014 Mar; 170(3):R109-19. PubMed ID: 24347425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple, rapid, and cost-effective microextraction by the packed sorbent method for quantifying of urinary free catecholamines and metanephrines using liquid chromatography-tandem mass spectrometry and its application in clinical analysis.
    Xiong X; Zhang Y
    Anal Bioanal Chem; 2020 May; 412(12):2763-2775. PubMed ID: 32130439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade.
    Schürfeld R; Pamporaki C; Peitzsch M; Rayes N; Sabri O; Rohm S; Biemann R; Sandner B; Tönjes A; Eisenhofer G
    Endocr Relat Cancer; 2024 Jan; 31(1):. PubMed ID: 37955319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
    Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.
    Goupil R; Fountoulakis S; Gordon RD; Stowasser M
    J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
    Därr R; Pamporaki C; Peitzsch M; Miehle K; Prejbisz A; Peczkowska M; Weismann D; Beuschlein F; Sinnott R; Bornstein SR; Neumann HP; Januszewicz A; Lenders J; Eisenhofer G
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):478-86. PubMed ID: 24102244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Accuracy of Salivary Metanephrines in Pheochromocytomas and Paragangliomas.
    Eijkelenkamp K; Osinga TE; van Faassen M; Kema IP; Kerstens MN; Pacak K; Sluiter WJ; Links TP; van der Horst-Schrivers ANA
    Clin Chem; 2021 Aug; 67(8):1090-1097. PubMed ID: 34096581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose Pheochromocytoma.
    Pommer G; Pamporaki C; Peitzsch M; Remde H; Deutschbein T; Nölting S; Müller LM; Braun L; Gruber S; Pecori A; Hampson S; Davies E; Stell A; Rossi GP; Lenzini L; Ceccato F; Timmers HJLM; Deinum J; Amar L; Blanchard A; Baron S; Fassnacht M; Dobrowolski P; Januszewicz A; Zennaro MC; Prejbisz A; Eisenhofer G
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3689-e3698. PubMed ID: 35767279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Plasma Catecholamines in Human Pheochromocytoma and Primary Hypertension Based on Liquid Chromatography Tandem Mass Spectrometry.
    Xue X; Chen H; Xia Q; He P; Lv Y; Liu P; Yang Y; Wu C; Gao Q; Peng J; Yu Y; Wang F; Qu W; Wang Z
    Ann Clin Lab Sci; 2019 Mar; 49(2):204-211. PubMed ID: 31028065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension.
    Mühlethaler-Mottet A; Uccella S; Marchiori D; La Rosa S; Daraspe J; Balmas Bourloud K; Beck Popovic M; Eugster PJ; Grouzmann E; Abid K
    Front Endocrinol (Lausanne); 2022; 13():1027856. PubMed ID: 36531507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory evaluation of pheochromocytoma and paraganglioma.
    Eisenhofer G; Peitzsch M
    Clin Chem; 2014 Dec; 60(12):1486-99. PubMed ID: 25332315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
    Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
    Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
    Wang K; Gao X; Zhang W; Sun N; Xie L; Cong H; Guo Y; Shi X; Zhou Z
    Scand J Clin Lab Invest; 2021 Nov; 81(7):564-572. PubMed ID: 34570657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biochemical diagnosis of pheochromocytoma and neuroblastomas].
    Candito M; Billaud E; Chauffert M; Cottet-Emard JM; Desmoulin D; Garnier JP; Greffe J; Hirth C; Jacob N; Millot F; Nignan A; Patricot MC; Peyrin L; Plouin PF
    Ann Biol Clin (Paris); 2002; 60(1):15-36. PubMed ID: 11830391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine.
    Peitzsch M; Novos T; Kaden D; Kurlbaum M; van Herwaarden AE; Müller D; Adaway J; Grouzmann E; McWhinney B; Hoad K; Woollard G; Kema I; Boot C; Fassnacht M; Sweep F; Loh TP; Horvath AR; Eisenhofer G
    Clin Chem; 2021 Aug; 67(8):1098-1112. PubMed ID: 33993248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of plasma fractionated free metanephrines by enzyme immunoassay in the diagnosis of pheochromocytoma and paraganglioma.
    Sarathi V; Pandit R; Jagtap V; Lila AR; Bandgar TR; Menon PS; Varthakavi P; Raghavan VP; Shah NS
    Endocr Pract; 2011; 17(5):759-65. PubMed ID: 21742610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenocortical Tumors and Pheochromocytoma/Paraganglioma Initially Mistaken as Neuroblastoma-Experiences From the GPOH-MET Registry.
    Kuhlen M; Pamporaki C; Kunstreich M; Wudy SA; Hartmann MF; Peitzsch M; Vokuhl C; Seitz G; Kreissl MC; Simon T; Hero B; Frühwald MC; Vorwerk P; Redlich A
    Front Endocrinol (Lausanne); 2022; 13():918435. PubMed ID: 35784570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma Metanephrines Yield Fewer False-Positive Results Than Urine Metanephrines in Patients With Obstructive Sleep Apnea.
    King TFJ; Mok Y; Dacay LM; Wong HS; Hsu PP; Tan A; Wong KM; Saffari SE; Lenders JWM; Puar TH
    J Clin Endocrinol Metab; 2024 Feb; 109(3):844-851. PubMed ID: 37721483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.